Home Applications 209241 Application 209241
Type NDA
Sponsor NEUROCRINE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 INGREZZA VALBENAZINE TOSYLATE CAPSULE;ORAL EQ 40MG BASE Yes No 002 INGREZZA VALBENAZINE TOSYLATE CAPSULE;ORAL EQ 80MG BASE Yes Yes 003 INGREZZA VALBENAZINE TOSYLATE CAPSULE;ORAL EQ 60MG BASE Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209241-001 INGREZZA VALBENAZINE TOSYLATE EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 N209241-002 INGREZZA VALBENAZINE TOSYLATE EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 N209241-003 INGREZZA VALBENAZINE TOSYLATE EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 2 · 99 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209241-001 8357697 2027-11-08 U-1995 2017-04-26 N209241-001 8357697 2027-11-08 U-3055 2017-04-26 N209241-001 8039627 2031-04-11 Drug substance, Drug product 2017-04-26 N209241-001 10065952 2036-10-28 U-1995 Drug substance, Drug product 2018-09-26 N209241-001 10065952 2036-10-28 U-3055 Drug substance, Drug product 2018-09-26 N209241-001 10844058 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 N209241-001 10844058 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 N209241-001 10851103 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 N209241-001 10851103 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 N209241-001 10851104 2036-10-28 U-1995 Drug substance 2020-12-18 N209241-001 10851104 2036-10-28 U-3055 Drug substance 2020-12-18 N209241-001 10906902 2036-12-22 Drug substance, Drug product 2021-03-03 N209241-001 10906903 2036-12-22 Drug substance, Drug product 2021-03-03 N209241-001 10919892 2036-12-22 Drug substance, Drug product 2021-03-03 N209241-001 10857137 2037-10-10 U-1995 2020-12-18 N209241-001 10857148 2037-10-10 U-1995 2020-12-18 N209241-001 10874648 2037-10-10 U-1995 2021-01-25 N209241-001 10874648 2037-10-10 U-3046 2021-01-25 N209241-001 10874648 2037-10-10 U-3055 2021-01-25 N209241-001 10912771 2037-10-10 U-1995 2021-03-03 N209241-001 10912771 2037-10-10 U-3055 2021-03-03 N209241-001 10912771 2037-10-10 U-3076 2021-03-03 N209241-001 10952997 2037-10-10 U-1995 2021-04-06 N209241-001 10993941 2037-10-10 U-1995 2021-05-19 N209241-001 11040029 2037-10-10 U-1995 2021-06-30 N209241-001 11439629 2037-10-10 U-3055 2023-09-14 N209241-001 11026939 2038-09-18 U-1995 Drug product 2021-06-30 N209241-001 11026939 2038-09-18 U-3055 Drug product 2021-06-30 N209241-001 11311532 2038-09-18 U-1995 Drug product 2022-05-17 N209241-001 11311532 2038-09-18 U-3055 Drug product 2022-05-17 N209241-001 11654142 2038-11-14 U-3055 2023-09-14 N209241-001 11026931 2039-08-14 U-1995 2021-06-30 N209241-001 10940141 2040-08-10 U-1995 2021-04-06 N209241-002 8357697 2027-11-08 U-1995 2017-10-27 N209241-002 8357697 2027-11-08 U-3055 2017-10-27 N209241-002 8039627 2031-04-11 Drug substance, Drug product 2017-10-27 N209241-002 10065952 2036-10-28 U-1995 Drug substance, Drug product 2018-09-26 N209241-002 10065952 2036-10-28 U-3055 Drug substance, Drug product 2018-09-26 N209241-002 10844058 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 N209241-002 10844058 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 N209241-002 10851103 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 N209241-002 10851103 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 N209241-002 10851104 2036-10-28 U-1995 Drug substance 2020-12-18 N209241-002 10851104 2036-10-28 U-3055 Drug substance 2020-12-18 N209241-002 10906902 2036-12-22 Drug substance, Drug product 2021-03-03 N209241-002 10906903 2036-12-22 Drug substance, Drug product 2021-03-03 N209241-002 10919892 2036-12-22 Drug substance, Drug product 2021-03-03 N209241-002 10857137 2037-10-10 U-1995 2020-12-18 N209241-002 10857148 2037-10-10 U-1995 2020-12-18 N209241-002 10874648 2037-10-10 U-1995 2021-01-25 N209241-002 10874648 2037-10-10 U-3046 2021-01-25 N209241-002 10874648 2037-10-10 U-3055 2021-01-25 N209241-002 10912771 2037-10-10 U-1995 2021-03-03 N209241-002 10912771 2037-10-10 U-3055 2021-03-03 N209241-002 10912771 2037-10-10 U-3076 2021-03-03 N209241-002 10952997 2037-10-10 U-1995 2021-04-06 N209241-002 10993941 2037-10-10 U-1995 2021-05-19 N209241-002 11040029 2037-10-10 U-1995 2021-06-30 N209241-002 11439629 2037-10-10 U-3055 2023-09-14 N209241-002 11026939 2038-09-18 U-1995 Drug product 2021-06-30 N209241-002 11026939 2038-09-18 U-3055 Drug product 2021-06-30 N209241-002 11311532 2038-09-18 U-1995 Drug product 2022-05-17 N209241-002 11311532 2038-09-18 U-3055 Drug product 2022-05-17 N209241-002 11654142 2038-11-14 U-3055 2023-09-14 N209241-002 11026931 2039-08-14 U-1995 2021-06-30 N209241-002 10940141 2040-08-10 U-1995 2021-04-06 N209241-003 8357697 2027-11-08 U-1995 2021-05-19 N209241-003 8357697 2027-11-08 U-3055 2021-05-19 N209241-003 8039627 2031-04-11 Drug substance, Drug product 2021-05-19 N209241-003 10065952 2036-10-28 U-1995 Drug substance, Drug product 2021-05-19 N209241-003 10065952 2036-10-28 U-3055 Drug substance, Drug product 2021-05-19 N209241-003 10844058 2036-10-28 U-1995 Drug substance, Drug product 2021-05-19 N209241-003 10844058 2036-10-28 U-3055 Drug substance, Drug product 2021-05-19 N209241-003 10851103 2036-10-28 U-1995 Drug substance, Drug product 2021-05-19 N209241-003 10851103 2036-10-28 U-3055 Drug substance, Drug product 2021-05-19 N209241-003 10851104 2036-10-28 U-1995 Drug substance 2021-05-19 N209241-003 10851104 2036-10-28 U-3055 Drug substance 2021-05-19 N209241-003 10906902 2036-12-22 Drug substance, Drug product 2021-05-19 N209241-003 10906903 2036-12-22 Drug substance, Drug product 2021-05-19 N209241-003 10919892 2036-12-22 Drug substance, Drug product 2021-05-19
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 121 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL RLD 2021-04-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209241-002 INGREZZA EQ 80MG BASE CAPSULE / ORAL AB RLD, RS 2017-10-04 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209241-003 INGREZZA EQ 60MG BASE CAPSULE / ORAL AB RLD 2021-04-23 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209241-001 INGREZZA EQ 40MG BASE CAPSULE / ORAL AB RLD 2017-04-11 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Observed Orange Book patent history# Patent history page 1 of 78 · 3,114 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N209241-001 8357697 2027-11-08 U-3055 2017-04-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 8357697 2027-11-08 U-1995 2017-04-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 8039627 2031-04-11 Drug substance, Drug product 2017-04-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10065952 2036-10-28 U-1995 Drug substance, Drug product 2018-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10065952 2036-10-28 U-3055 Drug substance, Drug product 2018-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10844058 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10844058 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10851103 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10851103 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10851104 2036-10-28 U-1995 Drug substance 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10851104 2036-10-28 U-3055 Drug substance 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10906902 2036-12-22 Drug substance, Drug product 2021-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10906903 2036-12-22 Drug substance, Drug product 2021-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10919892 2036-12-22 Drug substance, Drug product 2021-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10857137 2037-10-10 U-1995 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10857148 2037-10-10 U-1995 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10874648 2037-10-10 U-1995 2021-01-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10874648 2037-10-10 U-3046 2021-01-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10874648 2037-10-10 U-3055 2021-01-25 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10912771 2037-10-10 U-3055 2021-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10912771 2037-10-10 U-1995 2021-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10912771 2037-10-10 U-3076 2021-03-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10952997 2037-10-10 U-1995 2021-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10993941 2037-10-10 U-1995 2021-05-19 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11040029 2037-10-10 U-1995 2021-06-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11439629 2037-10-10 U-3055 2023-09-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11026939 2038-09-18 U-3055 Drug product 2021-06-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11026939 2038-09-18 U-1995 Drug product 2021-06-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11311532 2038-09-18 U-1995 Drug product 2022-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11311532 2038-09-18 U-3055 Drug product 2022-05-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11654142 2038-11-14 U-3055 2023-09-14 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 11026931 2039-08-14 U-1995 2021-06-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-001 10940141 2040-08-10 U-1995 2021-04-06 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 8357697 2027-11-08 U-1995 2017-10-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 8357697 2027-11-08 U-3055 2017-10-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 8039627 2031-04-11 Drug substance, Drug product 2017-10-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 10065952 2036-10-28 U-1995 Drug substance, Drug product 2018-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 10065952 2036-10-28 U-3055 Drug substance, Drug product 2018-09-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 10844058 2036-10-28 U-1995 Drug substance, Drug product 2020-12-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N209241-002 10844058 2036-10-28 U-3055 Drug substance, Drug product 2020-12-18 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 5 · 172 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 31 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 70370-1040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1040 INGREZZA Valbenazine Neurocrine Biosciences, I NDA Current 70370-1040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1048 INGREZZA Valbenazine Neurocrine Biosciences, I NDA Current 70370-1048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1060 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1060 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1060 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, I NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-1080 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, I NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2040 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, I NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current 70370-2048 INGREZZA Valbenazine Neurocrine Biosciences, Inc. NDA Current